Cartalax 20mg
Synthetic Tripeptide Bioregulator | Laboratory Use Only
Cartalax (also referenced as AED or T-31) is a synthetic tripeptide (Ala-Glu-Asp) from the Khavinson family of short-peptide bioregulators, developed at the St. Petersburg Institute of Bioregulation and Gerontology. It is the defined synthetic counterpart to a cartilage-derived peptide complex and is studied in fibroblast, chondrocyte, and renal cell culture models.
$70.00
Availability: 19 in stock
Product Overview
- Compound: Cartalax (H-Ala-Glu-Asp-OH, AED)
- Class: Short-chain tripeptide bioregulator
- Molecular formula and weight: C₁₂H₁₉N₃O₈, about 333.3 g/mol
- Common strength: 20 mg per vial (some sellers offer 25 mg; confirm yours)
- Format: Lyophilized powder, highly water-soluble
- Purity: Typically ≥98% to ≥99% by HPLC
- Documentation: Lot-specific Certificate of Analysis (COA)
Research Areas of Interest
- Fibroblast and chondrocyte gene expression in cell culture
- Extracellular matrix and collagen-related pathway markers
- Peptide interaction with DNA and histones in cultured cells
- Mesenchymal stem cell aging models
- Comparative studies with other Khavinson peptides
Storage and Handling
Store the lyophilized powder sealed and protected from light and moisture, at the temperature shown on your COA or label (commonly 2 to 8 °C, or −20 °C for long-term). Handle only in a laboratory setting by qualified personnel.Important Notice
For laboratory research use only. Not for human or veterinary use, not a drug or dietary supplement, and not intended to diagnose, treat, cure, or prevent any disease. Sold only to qualified researchers and institutions aged 18 and over.Related Products
